Jpmorgan Chase & CO Syneos Health, Inc. Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$34.5 - $42.19 $59.9 Million - $73.3 Million	-1,737,501 Reduced 75.81%	554,483 $23.4 Million
Q1 2023 May 18, 2023	BUY	$33.32 - $40.98 $5.89 Million - $7.25 Million	176,858 Added 8.36%	2,291,984 $81.6 Million
Q1 2023 May 11, 2023	SELL	$33.32 - $40.98 $2.25 Million - $2.77 Million	-67,615 Reduced 3.1%	2,115,126 $75.3 Million
Q4 2022 Feb 13, 2023	SELL	$25.32 - $51.45 $450,138 - $914,678	-17,778 Reduced 0.81%	2,182,741 $80.1 Million
Q3 2022 Nov 14, 2022	BUY	$46.5 - $79.14 $960,457 - $1.63 Million	20,655 Added 0.95%	2,200,519 $104 Million
Q2 2022 Aug 11, 2022	SELL	$63.06 - $84.75 $3.65 Million - $4.91 Million	-57,904 Reduced 2.59%	2,179,864 $156 Million
Q1 2022 May 11, 2022	BUY	$74.15 - $99.36 $1.03 Million - $1.38 Million	13,855 Added 0.62%	2,237,768 $181 Million
Q4 2021 Feb 10, 2022	SELL	$86.01 - $102.89 $15.5 Million - $18.5 Million	-179,784 Reduced 7.48%	2,223,913 $228 Million
Q3 2021 Nov 12, 2021	BUY	$84.7 - $96.31 $204 Million - $232 Million	2,403,697 New	2,403,697 $210 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.